Clarivate PLC

Clarivate PLC (CLVT) Stock Analysis

$1.610

+0.010 (+0.63%)At close

Loading chart…
High
1.610
Open
1.560
VWAP
1.59
Volume
2.85M
Mkt Cap
3.81B
Low
1.540
Amount
4.52M
EV/EBITDA, TTM
5.80

Clarivate Plc is a provider of transformative intelligence. The Company offers intelligence solutions, workflow solutions, and tech-enabled services to its customers. Its Intelligence solutions include up-to-date knowledge assets, combining data, structured taxonomies, and analytical models that transform complex information into actionable insights powered by a combination of artificial intelligence (AI)-enabled software and human expertise. It operates through two segments, which include Academia & Government (A&G), and Intellectual Property (IP). The Academia & Government segment connects trusted content, responsible technology, and editorial expertise to fuel academic success and advance national outcomes for institutions and users globally. The Intellectual Property segment provides intellectual property data, software, and helps companies drive innovation, law firms achieve practice excellence, and organizations manage and protect critical intellectual property assets.

clarivate.com

AI analysis of Clarivate PLC (CLVT)

Buy

Clarivate PLC (CLVT) is a good buy right now due to its recent strategic sale of the Life Sciences & Healthcare segment for $600 million, which is expected to enhance its focus and profitability. The current price of $1.61 is significantly below the analyst price target of $5 from Stifel, indicating a potential upside of over 200%. Additionally, the stock has shown a positive 5-day change of +8.78%, suggesting a recent upward momentum. However, the main risk is the company's substantial net loss of $268.6 million in Q2 2026, which reflects ongoing profitability challenges.

Valuation Metrics

The current forward P/E ratio for Clarivate PLC (CLVT) is 2.56, compared to its 5-year average forward P/E of 10.23.

Forward P/E

Undervalued
5Y Average P/E
10.23
Current P/E
2.56
Overvalued
16.15
Undervalued
4.32

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
16.15
Current EV/EBITDA
5.80
Overvalued
33.88
Undervalued
-1.58

Forward P/S

Undervalued
5Y Average P/S
2.06
Current P/S
0.51
Overvalued
3.35
Undervalued
0.77

Alphio AI Price Scenarios for CLVT

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%CLVT

$5.42

Scenario price

B

Base

Base · 50%CLVT

$4.71

Scenario price

B

Bear

Bear · 25%CLVT

$4.31

Scenario price

Whales holding CLVT

L

Lingotto Investment Management LLP

+ HoldingCLVT

+19.59%

3M Return

B

BW Gestao de Investimentos Ltda.

+ HoldingCLVT

+3.37%

3M Return

A

Atairos Management, L.P.

+ HoldingCLVT

-3.37%

3M Return

T

Timucuan Asset Management Inc

+ HoldingCLVT

-7.51%

3M Return

Events Timeline

2026-07-29 (ET)

06:30:00

Clarivate Reports Q2 Revenue of $587.3M

06:30:00

Clarivate Appoints Michael Easton as CFO

06:30:00

Clarivate Maintains FY26 Revenue Outlook at $2.3B to $2.42B

2026-07-14 (ET)

05:30:00

Clarivate Selected to Modernize France's National Academic Library System

2026-07-06 (ET)

16:30:00

Major Averages Open Higher as Chip Stocks Rebound

News

CLVT FAQ — answered by Alphio AI

Clarivate Plc is a provider of transformative intelligence. The Company offers intelligence solutions, workflow solutions, and tech-enabled services to its customers. Its Intelligence solutions include up-to-date knowledge assets, combining data, structured taxonomies, and analytical models that transform complex information into actionable insights powered by a combination of artificial intelligence (AI)-enabled software and human expertise. It operates through two segments, which include Academia & Government (A&G), and Intellectual Property (IP). The Academia & Government segment connects trusted content, responsible technology, and editorial expertise to fuel academic success and advance national outcomes for institutions and users globally. The Intellectual Property segment provides intellectual property data, software, and helps companies drive innovation, law firms achieve practice excellence, and organizations manage and protect critical intellectual property assets. It operates in the Industrials sector (SERVICES-COMPUTER PROCESSING & DATA PREPARATION industry).

Clarivate PLC (CLVT) is a good buy right now due to its recent strategic sale of the Life Sciences & Healthcare segment for $600 million, which is expected to enhance its focus and profitability. The current price of $1.61 is significantly below the analyst price target of $5 from Stifel, indicating a potential upside of over 200%. Additionally, the stock has shown a positive 5-day change of +8.78%, suggesting a recent upward momentum. However, the main risk is the company's substantial net loss of $268.6 million in Q2 2026, which reflects ongoing profitability challenges.

Community

More ↗

No posts yet

Sign up or log in to join the discussion

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading